Although it would be important to show the levels of TCF4 or Zbtb46 proteins following treatment with miR-124 mimic in naturally TCF4- or Zbtb46-expressing cells, we could not carry out those experiments in such cells as pDCs and pre-DCs but performed dual luciferase assays in HeLa cells instead

Although it would be important to show the levels of TCF4 or Zbtb46 proteins following treatment with miR-124 mimic in naturally TCF4- or Zbtb46-expressing cells, we could not carry out those experiments in such cells as pDCs and pre-DCs but performed dual luciferase assays in HeLa cells instead. roles of DC-specific transcription factors across the DC subsets have become Tolfenamic acid understood, the posttranscriptional mechanisms that regulate DC development are yet to be elucidated. MicroRNAs (miRNAs) are pivotal posttranscriptional regulators of gene expression in a myriad of biological processes, but their contribution to the immune system is just beginning to surface. In this study, our in-house probe collection was screened to identify miRNAs possibly involved in DC development and function by targeting the transcripts of relevant mouse transcription factors. Examination of DC subsets from the culture of mouse bone marrow with Tolfenamic acid Flt3 ligand identified high expression of miR-124 which was able to target the transcript of TCF4, a transcription factor critical for the development and homeostasis of pDCs. Further expression profiling of mouse DC subsets isolated from culture as well as via purification demonstrated that miR-124 was outstandingly expressed in CD24+ cDC1 cells compared to in pDCs and CD172+ cDC2 cells. These results imply that miR-124 is likely involved in the processes of DC subset development by posttranscriptional regulation of a transcription factor(s). with various culture conditions. Culture of DC progenitors in BM with the growth factor Flt3 ligand (Flt3L) produces a heterogeneous population containing both cDCs and pDCs, which are equivalent to their in situ counterparts with respect to cell surface marker expression, transcription factor reliance, cytokine production, receptor molecule expression, and antigen-presenting ability to T cells (4,5). Principally, DC subsets originated from Flt3L-cultured BM cells correspond to those of steady-state cDC populations. Beyond these mature DC subsets, relevant progenitor and precursor populations can also be identified and isolated from BM cells in steady state as well in culture with Flt3L (6,7). In light of these investigatory advances, the roles of transcription factors in DC development and their dynamic profiles Tolfenamic acid across the subsets have become well understood (8,9,10). For example, the transcription factor PU.1 has been described to play a role in the development of all DCs. Meanwhile, STAT5 is known to drive the development of cDCs over pDCs Fam162a through the inhibition of transcription factor interferon regulatory factor 8 (Irf8), whereas immunoglobin transcription factor 2 (TCF4) is known to drive pDC development over cDCs by directly activating Irf8 and other pro-pDC transcription factors such as SpiB (9,10,11). As such, a comprehensive group of transcription factors and their involvement in the particular Tolfenamic acid stages of DC development have been mapped. In contrast to these transcriptional mechanisms, posttranscriptional mechanisms that regulate DC development are less well understood. With the heterogeneity of subsets and wide-ranging function of DCs, the natural question arises on how DC differentiation and development is regulated besides the Tolfenamic acid orchestration of growth factors and transcription factors. Recently, increasing evidence has shown that microRNAs (miRNAs) play an important role in fine-tuning DC development and function. miRNAs are an evolutionarily conserved class of short, endogenous, non-coding RNAs about 19~23 nucleotides long that regulate protein synthesis by targeting the complementary 3′ untranslated region (UTR) of mRNAs for translational repression and degradation (12). miRNA biogenesis begins with the transcription of a miRNA gene to generate a primary miRNA (pri-miRNA) transcript, which is ultimately processed into a mature 19~23 bp miRNA and incorporated into an RNA-induced silencing complex (13) for the translational repression or degradation of target mRNAs. A key characteristic of miRNAs is that each has the ability to inhibit a myriad of mRNAs, and each mRNA can be targeted by many miRNAs. This is suggestive of a complex network of miRNAs surrounding DC development. miRNAs have been shown to be vital in controlling many processes within the immune system. Their involvement in regulating T- and B-lymphocyte development has been established of late and their wide-ranging roles in cell differentiation,.